| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/01/2007 | DE10141443B4 Verwendung von molekularbiologisch hergestellten, nicht-viralen Wirkstoffen zur Behandlung der Akne Using molecular biological manufactured, non-viral agents for the treatment of acne |
| 02/01/2007 | CA2616150A1 Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology |
| 02/01/2007 | CA2616004A1 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 01/31/2007 | EP1748048A1 Imidazopyridine compound |
| 01/31/2007 | EP1748044A1 Thiazole compound and use thereof |
| 01/31/2007 | EP1747786A2 Natural product in cream with anti-vitiligo therapeutic properties |
| 01/31/2007 | EP1746971A1 Dermatological composition for the treatment of pigmentary disorders of the skin |
| 01/31/2007 | EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 01/31/2007 | EP1303541A4 Gel compositions containing metronidazole |
| 01/31/2007 | CN1905891A Methods and compositions for the treatment of skin changes associated with aging and environmental damage |
| 01/31/2007 | CN1903352A Medicine for treating beriberi |
| 01/31/2007 | CN1903346A Traditional Chinese medicine for treating gastric carcinoma |
| 01/31/2007 | CN1903342A Extractive of flowers and leaves of pseudo-ginseng, prepn. method, quality control method and application thereof |
| 01/31/2007 | CN1903337A Traditional Chinese medicine oral prepn. for treating psoriasis |
| 01/31/2007 | CN1903303A Capsule for treating dermatosis |
| 01/31/2007 | CN1903297A Traditional Chinese medicine oral prepn. for treating leucoderma |
| 01/31/2007 | CN1903296A Cleaning cream for treating burns and skin-infection and prepn. method therefor |
| 01/31/2007 | CN1903291A Medicated liquor for treating burns |
| 01/31/2007 | CN1903286A Recovery medicated liquor contg. potato and its prepn. method |
| 01/31/2007 | CN1903282A Ointement for treating frostbite and its prepn. method |
| 01/31/2007 | CN1903270A Ointment for dissolving stasis and dispelling spots |
| 01/31/2007 | CN1903259A Method for extraction and separation of moutan bark |
| 01/31/2007 | CN1903257A Medicine for treating seborrheic baldness |
| 01/31/2007 | CN1903230A Traditional Chinese medicine for treating burns |
| 01/31/2007 | CN1903222A Method and recipe for preparing cockroach band aid |
| 01/31/2007 | CN1903214A Ointment containing red precipitate |
| 01/31/2007 | CN1903212A Application of methyl astragalin for preparing medicines |
| 01/31/2007 | CN1297554C Amido ether substituted imidazoquinolines |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/31/2007 | CN1297298C Antiradiation health tea for improving immunity |
| 01/31/2007 | CN1297294C Extemal remedy for treating eczema |
| 01/31/2007 | CN1297293C Boil treating medicine |
| 01/31/2007 | CN1297292C Burn treating medicine |
| 01/31/2007 | CN1297285C Becterin of Serratia marcescens for curing |
| 01/31/2007 | CN1297268C Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives |
| 01/31/2007 | CN1297266C Stabilized ascorbic acid derivatives |
| 01/31/2007 | CN1297250C Medicinal powder for eliminating human body off odour |
| 01/30/2007 | US7169951 Quinazoline derivatives and pharmaceutical applications thereof |
| 01/30/2007 | US7169930 Analogs of epothilone |
| 01/30/2007 | US7169925 Indole derivatives as interleukin-4 gene expression inhibitors |
| 01/30/2007 | US7169924 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 01/30/2007 | US7169811 Composition based on ethyl ester of linoleic acid and triethyl ester of citric acid for topical use in the treatment of seborrhea and acne |
| 01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
| 01/30/2007 | US7169794 Oxidation of a chemical intermediate |
| 01/30/2007 | US7169790 5-substituted 2-aryl-4-pyrimidinones |
| 01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 01/30/2007 | US7169779 Inhibitors of p38 |
| 01/30/2007 | US7169778 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 01/30/2007 | US7169603 Nucleic acid; a nucleotide sequence encoding a fusion polypeptide; fusion polypeptides containing alpha -MSH can be used to elicit a variety of biological responses, in vitro and in vivo |
| 01/30/2007 | US7169585 Papillomavirus vaccine |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169401 Topical skin care composition containing refined peanut oil |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/30/2007 | US7169379 Cosmetics |
| 01/30/2007 | CA2302017C Prevention of adhesions and excessive scar formation using angiogenesis inhibitors |
| 01/30/2007 | CA2255226C Use of cinnamic acid, or at least of one of its derivatives, in a cosmetic composition |
| 01/30/2007 | CA2210751C Anti-cd6 monoclonal antibodies and their uses |
| 01/30/2007 | CA2154098C Combinations of vasoactive substances with fatty acids to prevent hair loss |
| 01/25/2007 | WO2007011066A1 Fibroblast activator, collagen production promoter, collagen contraction promoter, hyaluronic acid production promoter, atp production promoter, melanin formation inhibitor, and agent for external application to the skin |
| 01/25/2007 | WO2007010965A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 01/25/2007 | WO2007010911A1 Agent for relieving wound and promoting wound recovery |
| 01/25/2007 | WO2007010840A1 MULTIPLE shRNA EXPRESSION VECTOR |
| 01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
| 01/25/2007 | WO2007010144A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 01/25/2007 | WO2007009657A1 Novel use of organic compounds |
| 01/25/2007 | WO2007009359A1 Thymosin beta 4 derivatives and use thereof |
| 01/25/2007 | WO2006128885A3 Uses of oligonucleotides stimulatory of the mesenchymal stem cell proliferation |
| 01/25/2007 | WO2006105219A3 T cell therapy for the treatment of cachexia and chronic diseases |
| 01/25/2007 | WO2006092668A3 Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same |
| 01/25/2007 | WO2006085144A3 Compositions containing high omega-3 and low saturated fatty acid levels |
| 01/25/2007 | WO2006085143A3 Improved bioactive agent compositions for repair of cell injuries |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021428 2-Substituted phenyl-1,3-dihydropyrazolo(4,3-c)cinnolines, e.g., N-[3-(tert-butyl-methyl-amino)-butyl]-4-(6-fluoro-3-oxo-1,3-dihydro-pyrazolo[4,3-c]cinnolin-2-yl)-benzamide, are CD80 antagonists capable of inhibiting the interactions between CD80 and CD28, used for treating autoimmune diseases |
| 01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 01/25/2007 | US20070021377 Pharmaceutical composition comprising a macrolide immunomodulator |
| 01/25/2007 | US20070020673 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 01/25/2007 | US20070020349 Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them |
| 01/25/2007 | US20070020270 Human serpin polypeptides |
| 01/25/2007 | US20070020262 Uses of mammalian cytokine: related reagents |
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | US20070020207 Cosmetic composition |
| 01/25/2007 | CA2615751A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 01/25/2007 | CA2614846A1 Acne treatment |
| 01/24/2007 | EP1746159A2 Immunostimulatory nucleic acid molecules |
| 01/24/2007 | EP1746095A1 Indanol derivative |
| 01/24/2007 | EP1746082A1 Salts of zinc and aliphatic haloid carboxylic acids for therapy of skin neoplasms and visible mucous coats |
| 01/24/2007 | EP1745800A1 Novel blt2-mediated disease, and blt2 binding agent and compound |
| 01/24/2007 | EP1745787A2 Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1-alpha 25-dihydroxy Vitamin D3 |
| 01/24/2007 | EP1745071A2 Msh-agonist tripeptide conjugates |
| 01/24/2007 | EP1745032A2 Cxcr1 and cxcr2 chemokine antagonists |
| 01/24/2007 | EP1744775A1 Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency |
| 01/24/2007 | EP1744769A1 Non-staining topical iodine composition |
| 01/24/2007 | EP1744763A1 Spinosyns for wound healing |
| 01/24/2007 | EP1744746A2 Use of melatonin in preventing postoperative complications |
| 01/24/2007 | EP1744739A2 Use of treprostinil to treat neuropathic diabetic foot ulcers |
| 01/24/2007 | EP1744726A1 Cosmetic and/or dermatological preparation and use thereof in the regulation of skin capillary blood flow |
| 01/24/2007 | EP1450785B1 Method of treating dermatoses using avermectin compound |
| 01/24/2007 | EP1377555B1 A dioxino[2,3-g]quinoline-9-carboxylic acid derivative as nk3 receptor antagonist |